ESC 365 - Cardiovascular events in CML patients treated with nilotinib: validation of the HFA-ICOS baseline risk score

ESC Premium Access

Cardiovascular events in CML patients treated with nilotinib: validation of the HFA-ICOS baseline risk score

Session: Cardio-oncology in practice

Topic: Cardio-Oncology

Speaker: Doctor M. Andres (Harefield, Uxbridge, GB)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Maria Sol Andres

Royal Brompton and Harefield Hospital, Harefield, Uxbridge (United Kingdom of Great Britain & Northern Ireland)

1 follower

2 more presentations in this session

The safety of standardized management of suspected cardiovascular immune-related events in patients treated by immunecheckpoints inhibitors

Speaker: Doctor F. Cribari (Rome, IT)

Unraveling immune checkpoint inhibitors effects on atherosclerosis: mechanisms and preventive approaches

Speaker: Doctor I. Nardi Agmon (Petah Tikva, IL)

Access the full session

Cardio-oncology in practice

Speakers: Doctor M. Andres, Doctor F. Cribari, Doctor I. Nardi Agmon

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources